Key points are not available for this paper at this time.
This review discusses the causes, pathogenesis, and clinical management of membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed glomerulonephritis cases. Current classification reflects advances in the understanding of this condition.
Sethi et al. (Thu,) studied this question.